UniSuper Management Pty Ltd Increases Holdings in Agilent Technologies, Inc. $A

UniSuper Management Pty Ltd boosted its position in Agilent Technologies, Inc. (NYSE:A) by 26.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,822 shares of the medical research company’s stock after buying an additional 7,157 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Agilent Technologies were worth $4,341,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Resona Asset Management Co. Ltd. grew its stake in shares of Agilent Technologies by 6.2% during the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after buying an additional 5,767 shares during the last quarter. CCLA Investment Management grew its position in Agilent Technologies by 10.5% during the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after acquiring an additional 97,312 shares during the last quarter. TrueMark Investments LLC purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $1,999,000. Nuance Investments LLC increased its stake in Agilent Technologies by 13.5% in the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after purchasing an additional 9,628 shares during the period. Finally, Osaic Holdings Inc. lifted its position in Agilent Technologies by 35.5% in the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after purchasing an additional 17,817 shares during the last quarter.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the sale, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 16,401 shares of company stock worth $2,468,962 over the last 90 days.

Wall Street Analyst Weigh In

A has been the topic of several recent analyst reports. Evercore ISI upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Hsbc Global Res raised shares of Agilent Technologies to a “strong-buy” rating in a report on Tuesday, January 20th. JPMorgan Chase & Co. boosted their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. UBS Group upped their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $164.50.

Agilent Technologies Stock Down 2.7%

Shares of NYSE A opened at $134.90 on Monday. The firm has a fifty day simple moving average of $143.36 and a two-hundred day simple moving average of $134.14. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $38.25 billion, a PE ratio of 29.52, a price-to-earnings-growth ratio of 3.92 and a beta of 1.29.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the previous year, the company earned $1.46 earnings per share. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.